Dan Troy is Integral Health’s chief business officer, chief administrative officer, and general counsel. He joined Integral from GlaxoSmithKline, where he was senior vice president and general counsel for 10 years. At GSK, Mr. Troy served on the corporate executive team and oversaw a legal department with more than 630 professionals (400+ attorneys) in more than 50 countries. His combined internal and external budgets exceeded $500 million. He led the successful takeover and integration of Human Genome Sciences and restructured the legal function internally and externally to save more than $100 million.
Mr. Troy was general counsel of the US Food and Drug Administration (FDA) from 2001 to 2004. In that capacity, he signed off on every guidance and major regulation issued by the FDA during that time, oversaw all agency litigation, and frequently served as the liaison to both the Department of Health and Human Services and the White House. He has been a partner at two nationally known law firms: Sidley Austin (2005–2008), where he specialized in advising companies in the health care sector; and Wiley, Rein & Fielding (1991–2001), where he practiced constitutional and administrative law with a particular focus on appellate litigation, including a successful appearance before the US Supreme Court.
Mr. Troy currently chairs the US Chamber Litigation Center, and has led the PhRma Law Section Executive Committee, the American Bar Association’s Section of Administrative Law and Regulatory Practice, and the Civil Justice Reform Committee. He is a member of the American Law Institute and serves on the Administrative Conference of the United States. Mr. Troy has been an associate scholar at the American Enterprise Institute. He earned a B.S. from the Cornell School of Industrial and Labor Relations and a J.D. from Columbia Law School, and clerked for Judge Robert H. Bork of the US Court of Appeals for the District of Columbia Circuit.